|
ASCET
Aspirin non-responsiveness and Clopidogrel Endpoint Trial
Ongoing trial
 |
Author(s) |
Pettersen A-ÅR, Seljeflot I, Abdelnoor M, Arnesen H |
 |
Title(s) |
Unstable angina, stroke, myocardial infarction and death in aspirin non-responders. A prospective, randomized trial. The ASCET (ASpirin non-responsiveness and Clopidogrel Endpoint Trial) design |
|
Reference(s) |
Scand Cardiovasc J 2004;38:353–6 |
|
Disease |
Coronary artery disease |
|
Purpose |
To investigate the effects of chronic ASA therapy and the effects of clopidogrel in ASA non-responders in patients with angiographically documented coronary artery disease |
|
Study design |
Randomised, open |
|
Follow-up |
Minimum 2 years |
|
Patients |
Aim 1000 patients, aged 18–80 years, with stable coronary artery disease |
|
Treatment regimen |
ASA, 160 mg/day, or clopidogrel, 75 mg/day |
|
Results |
Not yet available |
|
|
|
